SC Decides on PIL for Homeopathic Medicines to Treat COVID-19

A petition was listed before the Supreme Court on the use of Unani and Homeopathic medicines to treat COVID-19 on April 15, 2020. The petitioner argued that there are no medicines or treatments available for the novel coronavirus. Thus, he pleaded for exploration of alternate Unani and Homeopathic medicines to treat COVID-19. However, the Supreme Court dismissed the plea pursuing directions to the authorities for exploring possibilities of alternate Unani and Homeopathic medicines.

The bench comprising of Justice N V Ramana, Justice Sanjay Kishan Kaul and Justice B R Gavai held, “Corona is a new virus. We can’t experiment around. Let experts come up with a vaccine. Wait.” The court then dismissed the PIL  which was heard through video conference hosted on Zoom. The petition was filed by Dr C R Sivram.

A similar petition was filed by Advocate MS Vineeth. He had moved a PIL in the Kerala High Court on April 11, 2020. He sought for a direction to the State Government to implement the AYUSH notification. Additionally, he sought a permit to homoeopathy practitioners to practice their medicine while following the advisory. However, Justices AK Jayasankaran Nambiar and Shaji P Chaly have sought some time to obtain instructions from the Kerala Government on whether there is any prohibition on the treatment of COVID-19 patients by homoeopathy practitioners. The Court noting the request postponed the matter to April 17.

Click here to read more about COVID-19 lockdown.

About the Author

Ishan Harlalka
I am a 3rd year law aspirant pursuing BA LLB. I am deeply interested in learning and am always looking forward to gain knowledge about new subjects. In my leisure time, I try to read books of various genres and by different authors. As people from non-law background may find it difficult to understand legal provisions and jargons, I try to write in a way that my articles are easy to comprehend and after reading them, one can discuss them with others.

Did you enjoy this story?

Subscribe now to get the latest updates straight in your inbox. No spam, we promise.

Continue Reading